Health

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

This study is led by Dr. Longtao Huangfu, and Dr. Xiaoyang Wang (Peking University Cancer Hospital & Institute). A diet of fresh fruits and vegetables may reduce the prevalence of cancers, including GC (Eusebi et al., 2020; Liu et al., 2021).

news-medical

Join Our Newsletter

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero